My Member
Message Center
trending topics
market reports
-
MEDICAL JAPAN 2025 OSAKA Returns to Showcase Global Innovations
2025-02-17
-
Visit MEDICAL JAPAN 2023 TOKYO and take full advantage of the business opportunities!
2023-09-01
-
US to distribute 400 million free N95 masks at CVS, Walgreens in COVID fight
2022-01-21
-
Ethiopia receives additional 2.2 mln doses of Chinese-donated COVID-19 vaccines
2022-01-21
-
Hong Kong researchers say they develop novel material able to kill COVID-19 virus
2022-01-14
-
10 million more Chinese doses on way for Kenya
2022-01-14
-
Sino-African ties on track for a brighter future
2022-01-07
-
Efforts urged to boost COVID-19 vaccine production capacity in poor countries
2022-01-07
-
UAE approves Sinopharm's new protein-based COVID-19 vaccine
2022-01-07
-
UAE approves Sinopharm's new protein-based COVID-19 vaccine
2022-01-07
COVID-19 vaccine "Sputnik V" undergoing phase-3 clinical trials
2020-09-16
A medical worker inoculates a volunteer with the COVID-19 vaccine named "Sputnik V" during the phase-3 clinical trials in Moscow, Russia, on Sept. 15, 2020. (Photo by Alexander Zemlianichenko Jr/Xinhua)
A medical worker takes COVID-19 vaccine named "Sputnik V" out of a fridge during the phase-3 clinical trials in Moscow, Russia, on Sept. 15, 2020. (Photo by Alexander Zemlianichenko Jr/Xinhua)
A medical worker checks the temperature of a volunteer before inoculating her with the new COVID-19 vaccine named "Sputnik V" during the phase-3 clinical trials in Moscow, Russia, on Sept. 15, 2020. (Photo by Alexander Zemlianichenko Jr/Xinhua)
A medical worker shows an electronic bracelet for monitoring the health of volunteers who take part in the phase-3 clinical trials of COVID-19 vaccine named "Sputnik V" in Moscow, Russia, on Sept. 15, 2020. (Photo by Alexander Zemlianichenko Jr/Xinhua)
Photo taken on Sept. 15, 2020 shows Russia's new COVID-19 vaccine named "Sputnik V" during the phase-3 clinical trials in Moscow, Russia. (Photo by Alexander Zemlianichenko Jr/Xinhua)
(People's Daily)
